Gain detailed insights into the trading activity of Congress members for RELX on our government trades page. Stay updated on how elected officials are investing in RELX.

RELX - Government Trades

RELX

RELX is a global provider of information-based analytics and decision tools for professional and business customers in various industries. The company serves sectors such as science and medical research, risk management, and legal. In addition, RELX organizes large-scale digital and face-to-face events such as industry trade shows. Around 60% of revenue is generated in North America and about 20% in Europe.

AI illustration

Tech

AADR

APIE

IDVO

PowerShares ETF Trust International Dividend Achievers Portfolio

PRAY

LexisNexis has launched Nexis+ AI, an AI-powered research platform that provides access to 20,000+ news providers to quickly extract and analyze business, financial, and legal information.

LexisNexis Legal &amp; Professional Launches AI Research Tool Nexis+ AI

Keir Starmer

Specialty ETFs

Politics

Global

Markets

Trading Ideas

ETFs

EWUS

FLGB

GLNCY

HSBC

SHEL

New leadership in the United Kingdom could make several sectors standout going forward. Here&#39;s what experts are saying after the election.

United Kingdom Stocks, ETFs To Watch After Keir Starmer, Labour Party Win

Analyst Color

Upgrades

Price Target

Analyst Ratings

Movers

Shares of Relx PLC (NYSE: RELX) were climbing on Wednesday.

The company is “well positioned on generative AI to strengthen its existing data and IP competitive advantage,” according to Goldman Sachs.

Goldman Sachs Is Bullish On Relx: Why It&#39;s A Generative AI Play

News

General

LexisNexis Acquires Aistemos And Its Cipher Classification Platform For Undisclosed Sum

Travel

RELX&#39;s Cirium Launches Satellite-Based Aircraft Maintenance Tracking Feature

TWTR

As investors, the name of the game is profit REGARDLESS of brand names.

The mistake many budding investors make is thinking the brand name is where the profit lies when, in fact, profit lies in the performance of the asset. 

3 Obscure Stocks That Are Already Outperforming The Index

Penny Stocks

Pre-Market Outlook

AAPL

ABUS

AHPI

AMAG

AMBO

ARAV

ARCT

ASNA

AUPH

BCOV

BEDU

BGFV

BLDP

BNTX

BVXV

CBAY

CLIR

CNTG

CTXS

DMPI

ENTG

ENTX

EVSI

EYEN

GNCA

GTLS

HMHC

IBIO

IMRN

INUV

JMIA

KGJI

LLNW

LTBR

MGEN

MIST

MOGO

MOGU

NMRD

NTGR

NWGI

PLXS

QFIN

RMBL

RNET

SALM

TLSA

TNXP

UFPI

XSPA

76 Biggest Movers From Yesterday

Intraday Update

BCLI

CLDX

IMMP

PRVL

64 Stocks Moving In Thursday&#39;s Mid-Day Session

ABMD

ACBI

ACCO

ACEL

ACGL

ADOM

AERI

AGEN

AIRG

ALEX

ALLE

ALSN

AMCX

ANTM

AOSL

APYX

AQUA

ARCW

ARES

ARNC

ASRV

ASTC

ATEC

ATHM

ATRS

ATTO

AUTO

AVAL

AVNS

AWSM

AZPN

BANR

BBDO

BCOR

BCSF

BDSI

BECN

BFST

BHLB

BKNG

BMRC

BNED

BOKF

Stocks That Hit 52-Week Lows On Monday

AACG

AAOI

ABCB

ACHC

ACHV

ACIU

ACRE

ACRX

ACST

ACTG

ADES

ADMP

ADMS

ADNT

ADPT

ADTN

AEHR

AEIS

AEZS

AFGC

AFIN

AFMD

AGFS

AGLE

AGRO

AGYS

AIMC

AIMT

AINV

AIRT

AKCA

AKTS

AKTX

ALBO

ALDX

ALGN

ALGT

RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX PLC

While Tesla Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) sales in the U.S. have been <a href="https://www.benzinga.com/markets/equities/24/07/39595720/tesla-deliveries-fall-for-second-straight-quarter-but-stock-takes-off-as-q2-numbers-exceed-expec">dropping since the start of the year</a>, South Korean automaker Hyundai Motor (OTC:<a class="ticker" href="https://www.benzinga.com/stock/HYMTF#OTC">HYMTF</a>) and Japanese player Toyota Motor Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>) have been gaining ground in the country. 
Tesla Sales Drop: Tesla sales in the U.S. fell by nearly 10% since the start of the year and through the end of the second quarter, according to Kelley Blue Book estimates. Tesla does not segment its deliveries geography-wise, leaving third-party data as the sole means of tracking their sales in the country. 
As per the data, Tesla sold 304,451 units in the first half of the year as opposed to 336,892 vehicles in the corresponding period of last year.
While the sales drop was experienced across Tesla&#8217;s lineup, Model 3 sales took the largest hit. The company sold only 73,552 Model 3 sedans in the first half of this year as opposed to 112,791 units in the first half of 2023, likely due to the production ramp of the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38511618/tesla-researcher-thinks-ev-giants-biggest-challenge-in-q2-comes-from-one-of-its-cas">updated Model 3</a> at the company&#8217;s Fremont factory.
Tesla introduced the updated version of the Model 3 in the U.S. market <a href="https://www.benzinga.com/news/24/01/36570546/you-can-finally-order-teslas-new-model-3-in-america-heres-its-starting-price">in January.</a> 
Foreign Players Sell More EVs: But despite the American EV giant dropping in sales, foreign players have gained ground. Toyota sold 9,468 EVs in the period, marking a jump of 159% year-on-year. Toyota&#8217;s luxury brand Lexus, meanwhile, saw EV sales jump about 405% to 5,639 units, owing to the rise in popularity of its Lexus RZ electric SUV.
South Korea&#8217;s Hyundai too is rising in popularity in the region. While Hyundai saw its EV sales surge 34% to 29,105 units owing to the popularity of its <a href="https://www.benzinga.com/news/24/07/39630731/mustang-mach-e-drives-fords-q2-ev-sales-ahead-of-gm-but-its-still-just-a-fraction-of-elon-musks-tesl">Ioniq models</a>, its sister brand Kia saw sales jump 104% to 27,634 units.
Hyundai&#8217;s luxury brand Genesis also marked a nearly 27% growth in sales to 3,241 units, with the popularity of its GV70 Performance SUV making up for the drop in sales of its other EVs including the G80.
Other Domestic Player Performance: Foreign brands are not alone in their EV sales growth. Michigan-based Ford Motor Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) <a href="https://www.benzinga.com/news/24/07/39630731/mustang-mach-e-drives-fords-q2-ev-sales-ahead-of-gm-but-its-still-just-a-fraction-of-elon-musks-tesl">saw a 71.8% jump in EV sales</a> in the first six months of 2024 to 44,180 units, while American EV startup Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) registered a 33% rise in sales to 27,378, according to Kelley Blue Book data.
General Motors&#8216; (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) Cadillac brand also <a href="https://www.benzinga.com/news/24/07/39612749/60-000-cadillac-lyriq-drives-gms-q2-ev-sales-after-bolt-is-discontinued">saw sales rise by 465% to 13,094 units, owing to a rise in sales of its Lyriq SUV</a> while Chevrolet EV sales dropped by nearly 41% to 19,918 units, likely due to the stop in production of its Bolt EV in December.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read More:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39877043/tesla-fsd-to-allow-users-to-wear-sunglasses-starting-with-version-12-5-elon-musk-tells-quake-video-g">Tesla FSD To Allow Users To Wear Sunglasses Starting With Version 12.5, Elon Musk Tells Quake Video Game Developer: &#8216;Tesla Has Done So Much&#8230;&#8217;</a></li>
</ul>
Image made via photos on Shutterstock

HYMTF

RIVN

TSLA

Should Elon Musk Be Worried? Toyota, Hyundai, And Ford Challenge Tesla On Home Turf With More EVs On US Roads As Billionaire's Auto Giant Faces Sales Slump

Morgan Stanley analyst Benjamin Swinburne downgrades Interpublic Gr of Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPG#NYSE">IPG</a>) from Equal-Weight to Underweight and lowers the price target from $34 to $28.

Downgrades

Morgan Stanley Downgrades Interpublic Gr of Cos to Underweight, Lowers Price Target to $28

Biotricity Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTCY#NASDAQ">BTCY</a>), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced ongoing improvements in operational efficiency, scalability and margin performance driven by the latest enhancements to the company&#39;s proprietary AI Cloud platform.
The latest version of Biotricity&#39;s AI Cloud has improved the company&#39;s tech stack efficiency by&nbsp;20%, which is expected to result in a topline margin improvement of 200 to 300 basis points (2 to&nbsp;3%) in the coming quarters. The next version of the AI Cloud, currently under development, is anticipated to enhance the tech stack by another&nbsp;20%, contributing to an additional margin improvement of 100 to 200 basis points (1 to&nbsp;2%). These across-the-board improvements are accelerating Biotricity&#39;s path to breakeven and achieving positive cash flow.
&quot;Our focus on AI and technology-driven efficiencies continues to bear fruit,&quot; said Dr. Waqaas Al-Siddiq, founder and CEO of Biotricity. &quot;The latest upgrades to our AI Cloud platform are not just technical achievements; they are key drivers in improving our operational margins, supporting scale and expediting our path to profitability. With each iteration, we are pushing the boundaries of what&#39;s possible in remote cardiac monitoring and healthcare technology.&quot;
Biotricity is developing one the most comprehensive AI Cloud platforms for cardiac care. The platform leverages over 500 billion beats of anonymized data to build predictive cardiac AI models for improved diagnoses and faster interventions. These models enable more accurate analyses and improved operational efficiency, supporting physicians in diagnosing more patients with the same resources.
Biotricity is targeting a&nbsp;$35 billion&nbsp;total addressable market opportunity. With its solutions utilized daily by cardiologists across 35 states and hundreds of centers, Biotricity is capturing a growing market share in cardiology. This growth is bolstered by a high retention rate of approximately&nbsp;99%&nbsp;and a recurring revenue base with strong LTV-to-CAC ratios.

BTCY

Biotricity's AI Cloud Upgrades Drive Operational Gains and Path to Profitability

WIIM

Lennar shares are trading lower after Goldman Sachs downgraded the stock from Buy to Neutral and lowered its price target from $180 to $174.

In addition, the Agreement ends all existing credit ties with the Agreement parties, removes the existing lien against Talicia&reg; and restores control over cash collections back to RedHill.

Biotech

Health Care

Redhill Biopharma Terminates Agreement With Movantik Acquisition, Valinor Pharma, And Hcr Redhill, And Received ~$9.9M In Cash And Gained Full Control Over An Additional $0.74M Currently Held In Restricted Account


Tommy TubervilleSenate (R-AL)	$1K - $15K	stock	Sale	Jun 14, 2024	May 03, 2024	Senate
Daniel GoldmanHouse (D-NY)	$50K - $100K	stock	Sale	Aug 13, 2023	Jul 10, 2023	House
Daniel GoldmanHouse (D-NY)	$15K - $50K	stock	Purchase	Mar 20, 2023	Feb 27, 2023	House
Tommy TubervilleSenate (R-AL)	$1K - $15K	stock	Purchase	Nov 10, 2022	Oct 06, 2022	Senate

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Government Trades

RELX PLC

top performing RELX trades